Dai Lu

Title: Dai Lu: Innovator in Cannabinoid Research

Introduction

Dai Lu is a prominent inventor based in Boston, MA (US), known for his significant contributions to cannabinoid research. He holds a total of 5 patents, showcasing his innovative work in the field.

Latest Patents

Among his latest patents, Dai Lu has developed compounds related to Cannabinergic lipid ligands. These lipid compounds exert diverse effects in the endocannabinoid system, including the regulation of CB1 and CB2 receptors. Some compounds demonstrate improved receptor binding affinity and selectivity, as well as enhanced bio-stability. Additionally, these compounds can regulate enzymes that moderate the bio-disposal of endogenous cannabinoids, such as fatty acid amide hydrolase (FAAH), and inhibit the anandamide transporter. Another notable patent involves Bicyclic cannabinoids, which are presented along with methods of preparation and use. When administered in therapeutically effective amounts, these compounds can elicit physiological responses beneficial for treating various conditions.

Career Highlights

Dai Lu is affiliated with the University of Connecticut, where he continues to advance his research in cannabinoid science. His work has garnered attention for its potential therapeutic applications.

Collaborations

Dai Lu collaborates with esteemed colleagues, including Alexandros Makriyannis and Atmaram Khanolkar, further enhancing the impact of his research.

Conclusion

Dai Lu's innovative work in cannabinoid research exemplifies the potential of lipid compounds in therapeutic applications. His contributions continue to shape the future of cannabinoid science and its medical implications.